General Information of the Compound
Compound ID |
CP0324342
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
4-Iodo-N-{2-[4-(2-methoxy-phenyl)-piperazin-1-yl]-ethyl}-N-pyridin-2-yl-benzamide
Show/Hide
|
||||||||||||||||||
Synonyms |
155204-23-2
4-(2'-methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine
4-Iodo-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-2-pyridinylbenzamide
4-Mppi
4-iodo-N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylbenzamide
AC1L1INV
AC1Q4PHY
Benzamide, 4-iodo-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-2-pyridinyl-
C25H27IN4O2
CHEMBL29027
GTPL68
Lopac-M-204
Lopac0_000874
NCGC00015638-01
P-MPPI
benzamide, 4-iodo-n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-n-2-pyridinyl-
p-MPPI
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C25H27IN4O2
|
||||||||||||||||||
Molecular Weight |
542.421
|
||||||||||||||||||
Canonical SMILES |
COc1ccccc1N1CCN(CCN(C(=O)c2ccc(I)cc2)c2ccccn2)CC1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C25H27IN4O2/c1-32-23-7-3-2-6-22(23)29-17-14-28(15-18-29)16-19-30(24-8-4-5-13-27-24)25(31)20-9-11-21(26)12-10-20/h2-13H,14-19H2,1H3
Show/Hide
|
||||||||||||||||||
InChIKey |
DHMLNZRDVQLQBB-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
155204-23-2
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( P-MPPI )
Drug Name | P-MPPI | ||
---|---|---|---|
Target(s) |
5-HT 1A receptor (HTR1A)
Antagonist
|